Therapeutic interventions for symptomatic treatment in Huntington's disease, Cochrane Database Syst Rev, vol.8, p.6456, 2009. ,
Huntington's disease: from molecular pathogenesis to clinical treatment, Lancet Neurol, vol.10, pp.83-98, 2011. ,
Pharmacologic approaches to the treatment of Huntington's disease, Mov Disord, vol.27, pp.31-41, 2012. ,
Evidencebased guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology, Neurology, vol.79, pp.597-603, 2012. ,
Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?, Mov Disord, vol.29, pp.1404-1417, 2014. ,
A Europe-wide assessment of current medication choices in Huntington's disease, Mov Disord, vol.23, p.1788, 2008. ,
An international survey-based algorithm for the pharmacologic treatment of chorea in Huntington's disease, PLoS Curr, vol.3, 2011. ,
Cognitive and behavioral changes in Huntington disease before diagnosis, Handb Clin Neurol, vol.144, pp.69-91, 2017. ,
Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial, Neurology, vol.66, pp.366-72, 2006. ,
Tiapride versus placebo: a double-blind comparative study in the management of Huntington's chorea, Curr Med Res Opin, vol.9, pp.329-367, 1984. ,
A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia, J Neurol Neurosurg Psychiatry, vol.47, pp.844-851, 1984. ,
Clinical characterization of dystonia in adult patients with Huntington's disease, Eur J Neurol, vol.24, pp.1140-1147, 2017. ,
L-dopa and juvenile Huntington's disease, Lancet, vol.2, p.1066, 1969. ,
Huntington's chorea: the rigid form (Westphal variant) treated with levodopa, Med J Aust, vol.1, pp.393-397, 1974. ,
Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome, J Neurol Neurosurg Psychiatry, vol.68, pp.238-279, 2000. ,
Unusual early-onset Huntingtons disease, J Child Neurol, vol.18, pp.429-461, 2003. ,
Seven cases of Huntington's disease in childhood and levodopa induced improvement in the hypokinetic-rigid form, Clin Neurol Neurosurg, vol.82, pp.251-61, 1980. ,
Markedly asymmetrical parkinsonism as a leading feature of adult-onset Huntington's disease, Mov Disord, vol.19, pp.854-860, 2004. ,
Physiotherapy clinical guidelines for Huntington's disease, Neurodegener Dis Manage, vol.2, pp.21-31, 2012. ,
Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators, BMC Neurol, vol.9, p.62, 2009. ,
Tetrabenazine in the treatment of Huntington's chorea, Med J Aust, vol.1, pp.583-587, 1976. ,
I03 swallowing function in the early, middle and late stages of Huntington's disease, J Neurol Neurosurg Psychiatry, p.58, 2014. ,
Dysphagia in Huntington's disease: a 16-year retrospective, Dysphagia, vol.7, pp.106-120, 1992. ,
Home program of speech therapy in Huntington's disease, J Med Speech Lang Pathol, vol.18, pp.1-9, 2010. ,
Adult onset myoclonic Huntington's disease, Mov Disord, vol.8, pp.201-206, 1993. ,
Intention myoclonus in Huntington's disease, Bull Los Angeles Neurol Soc, vol.41, pp.82-86, 1976. ,
Myoclonus and Huntington's chorea: description of a case, Ital J Neurol Sci, vol.1, pp.189-91, 1980. ,
Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's disease patients: a case series, BMC Neurol, vol.6, p.11, 2006. ,
Cortical myoclonus in Huntington's disease, Mov Disord, vol.9, pp.633-674, 1994. ,
Myoclonus in adult Huntington's disease, Ann Neurol, vol.29, pp.213-218, 1991. ,
EEG characteristics in juvenile Huntington's disease: a case report and review of the literature, Epileptic Disord, vol.5, pp.145-153, 2003. ,
Myoclonic and major seizures in early adult Huntington's chorea: case-report and electro-clinical findings, Clin Electroencephalogr, vol.11, pp.44-51, 1980. ,
Spectrum of gait impairments in presymptomatic and symptomatic Huntington's disease, Mov Disord, vol.23, pp.1100-1107, 2008. ,
Evolution of locomotion disorders in Huntington's disease, Neurophysiol Clin, vol.38, pp.117-142, 2008. ,
Effects of an intensive rehabilitation programme on patients with Huntington's disease: a pilot study, Clin Rehabil, vol.21, pp.603-616, 2007. ,
Effects of a one year intensive multidisciplinary rehabilitation program for patients with Huntington's disease: a prospective intervention study, PLoS Curr, vol.5, 2013. ,
Effects of a two-year intensive multidisciplinary rehabilitation program for patients with Huntington's disease: a prospective intervention study, PLoS Curr, vol.6, 2014. ,
J04 The effect of video game-based exercise on dynamic balance and mobility in individuals with Huntington's disease, J Neurol Neurosurg Psychiatry, p.40, 2010. ,
A randomized feasibility study of a 12-week community-based exercise program for people with Huntington's disease, J Neurol Phys Ther, vol.37, pp.149-58, 2013. ,
Task-specific training in Huntington disease: a randomized controlled feasibility trial, Phys Ther, vol.94, pp.1555-68, 2014. ,
Effectiveness of intensive neurorehabilitation in patients with Huntington's disease, Eur J Phys Rehabil Med, vol.49, pp.189-95, 2013. ,
What effect does a structured home-based exercise programme have on people with Huntington's disease? A randomized, controlled pilot study, Clin Rehabil, vol.27, pp.646-58, 2013. ,
Velocity modulation and rhythmic synchronization of gait in Huntington's disease, Mov Disord, vol.14, pp.808-827, 1999. ,
Physical therapy in Huntington's disease-toward objective assessments?, Eur J Neurol, vol.20, pp.389-93, 2013. ,
The effects of physiotherapy with PNF concept on gait and balance of patients with Huntington's disease -pilot study, Neurol Neurochir Pol, vol.49, pp.354-361, 2015. ,
Olanzapine for Huntington's disease: an open label study, Clin Neuropharmacol, vol.25, pp.263-268, 2002. ,
High-dose olanzapine in Huntington's disease, Int Clin Psychopharmacol, vol.17, pp.91-94, 2002. ,
Aripiprazole in the treatment of Huntington's disease: a case series, Neuropsychiatr Dis Treat, vol.5, pp.1-4, 2009. ,
Treatment of Huntington's chorea with sulpiride, S Afr Med J, p.169, 1991. ,
The impact of different types of assistive devices on gait measures and safety in Huntington's disease, PLoS ONE, vol.7, p.30903, 2012. ,
Treatment of bruxism in Huntington's disease with botulinum toxin, J Neuropsychiatry Clin Neurosci, vol.16, pp.171-174, 2000. ,
A double-blind trial of tetrabenazine, thiopropazate, and placebo in patients with chorea, Lancet, vol.1, pp.104-111, 1974. ,
Patient and caregiver quality of life in Huntington's disease, Mov Disord, vol.23, pp.721-727, 2008. ,
The effect of multidisciplinary rehabilitation on brain structure and cognition in Huntington's disease: an exploratory study, Brain Behav, vol.5, p.312, 2015. ,
Improved executive function and callosal white matter microstructure after rhythm exercise in Huntington's disease, J Huntingtons Dis, vol.3, pp.273-83, 2014. ,
The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation, Mov Disord, vol.29, pp.673-83, 2014. ,
Speech timing in Parkinson's and Huntington's disease, Brain Lang, vol.32, pp.90124-90130, 1987. ,
Comprehension of complex discourse in different stages of Huntington's disease, Int J Lang Commun Disord, vol.45, pp.656-69, 2010. ,
Using talking mats to support communication in persons with Huntington's disease, Int J Lang Commun Disord, vol.45, pp.523-559, 2010. ,
Social cognition in Huntington's disease: a meta-analysis, Behav Brain Res, vol.297, 2016. ,
Episodic memory in dementia: characteristics of new learning that differentiate Alzheimer's, Huntington's, and Parkinson's diseases, Arch Clin Neuropsychol, vol.25, pp.396-409, 2010. ,
Time processing in Huntington's disease: a group-control study, PLoS ONE, vol.2, p.1263, 2007. ,
Variability in interval production is due to timing-dependent deficits in Huntington's disease, Mov Disord, vol.29, pp.1516-1538, 2014. ,
The basal ganglia in perceptual timing: timing performance in Multiple System Atrophy and Huntington's disease, Neuropsychologia, vol.52, pp.73-81, 2014. ,
Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits, Brain, pp.1349-64, 2000. ,
Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease, Parkinsonism Relat Disord, vol.25, pp.58-64, 2016. ,
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY), J Neurol Neurosurg Psychiatry, vol.85, pp.1411-1419, 2014. ,
Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study, J Psychiatr Res, vol.47, pp.1423-1454, 2013. ,
Results of the citalopram to enhance cognition in Huntington disease trial, Mov Disord, vol.29, pp.401-406, 2014. ,
ECT in genetically confirmed Huntington's disease, J Neuropsychiatry Clin Neurosci, vol.8, pp.209-219, 1996. ,
ECT as a treatment for depression in Huntington's disease, J Neuropsychiatry Clin Neurosci, vol.6, pp.154-163, 1994. ,
ECT in the treatment of organic psychosis in Huntington's disease, Convuls Ther, vol.3, pp.145-50, 1987. ,
Suicidal ideation assessment in individuals with premanifest and manifest Huntington disease, J Huntingtons Dis, vol.7, pp.239-288, 2018. ,
PREDICT-HD Investigators of the Huntington Study Group. Suicidal behavior in prodromal Huntington disease, Neurodegener Dis, vol.8, pp.483-90, 2011. ,
Psychopathology in verified Huntington's disease gene carriers, J Neuropsychiatry Clin Neurosci, vol.19, pp.441-449, 2007. ,
Sertraline in the treatment of severe aggressiveness in Huntington's disease, J Neuropsychiatry Clin Neurosci, vol.8, pp.338-378, 1996. ,
Fluoxetine in the treatment of Huntington's disease, Psychopharmacology (Berl), vol.153, pp.264-270, 2001. ,
Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort, Neurology, vol.9, pp.1023-1027, 1995. ,
Risperidone long-acting injection and Huntington's disease: case series with significant psychiatric and behavioural symptoms, Int Clin Psychopharmacol, vol.26, pp.114-123, 2011. ,
Improvement of Huntington's disease with olanzapine and valproate, N Engl J Med, vol.343, pp.973-977, 2000. ,
Lamotrigine in motor and mood symptoms of Huntington's disease, World J Biol Psychiatry, vol.9, pp.147-156, 2008. ,
Apathy and the basal ganglia, J Neurol, pp.54-61, 2006. ,
Irritability in a prospective cohort of Huntington's disease mutation carriers, J Neuropsychiatry Clin Neurosci, vol.27, pp.206-218, 2015. ,
Short-term effects of olanzapine in Huntington disease, Neuropsychiatry Neuropsychol Behav Neurol, vol.14, pp.69-72, 2001. ,
Risperidone and the treatment of psychiatric, motor, and cognitive symptoms in Huntington's disease, Ann Clin Psychiatry, vol.20, pp.1-3, 2008. ,
Quality of life in Huntington's disease: a comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners, J Huntingtons Dis, vol.2, pp.159-75, 2013. ,
Obsessive compulsive disorder in huntington disease: a case of isolated obsessions successfully treated with sertraline, Neuropsychiatry Neuropsychol Behav Neurol, vol.15, pp.216-225, 2002. ,
Hypersexual features in Huntington's disease, Singapore Med J, vol.52, pp.131-134, 2011. ,
Cyproterone for treatment of hypersexuality in an elderly Huntington's disease patient, Prog Neuropsychopharmacol Biol Psychiatry, vol.32, pp.1994-1999, 2008. ,
Leuprolide acetate for exhibitionism in Huntington's disease, Mov Disord, vol.9, pp.353-360, 1994. ,
Successful multimodality treatment of severe behavioral disturbance in a patient with advanced Huntington's disease, Am J Psychiatry, vol.158, pp.1966-72, 2001. ,
Clinical experience with risperidone and memantine in the treatment of Huntington's disease, Acta Neurol Scand, vol.105, pp.1353-1358, 2002. ,
Psychiatric and neuropsychological abnormalities in Huntington's disease: a case study, Ann Clin Psychiatry, vol.10, pp.117-137, 1998. ,
Use of risperidone in psychosis associated with Huntington's disease, Am J Geriatr Psychiatry, vol.6, pp.347-356, 1998. ,
Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease, J Neuropsychiatry Clin Neurosci, vol.22, p.5, 2010. ,
Risperidone in treatment of choreoathetosis of Huntington's disease, J Clin Psychopharmacol, vol.17, pp.134-139, 1997. ,
Efficacy of clozapine in the course of Huntington chorea: apropos of a clinical case, Encephale, vol.27, pp.169-71, 2001. ,
Aripiprazole treatment for choreoathetoid and psychotic symptoms of Huntington's disease, J Neuropsychiatry Clin Neurosci, vol.25, p.31, 2013. ,
Quetiapine in the treatment of behavioral disturbances in patients with Huntington's disease, Psychosomatics, vol.47, pp.70-72, 2006. ,
Quetiapine in the management of psychosis secondary to huntington's disease: a case report, Can J Psychiatry, vol.49, p.413, 2004. ,
Treatment of psychotic and behavioral symptoms with clozapine, aripiprazole, and reboxetine in a patient with Huntington's disease, Int Clin Psychopharmacol, vol.28, pp.214-220, 2013. ,
Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea, Neurology, vol.41, p.156, 1991. ,
Aripiprazole effects on psychosis and chorea in a patient with Huntington's disease, Am J Psychiatry, vol.165, pp.1207-1215, 2008. ,
Modified electroconvulsive therapy for the treatment of refractory schizophrenia-like psychosis associated with Huntington's disease, J Neurol, vol.260, pp.312-316, 2013. ,
Experience with intramuscular zuclopenthixol and medroxyprogesterone acetate in the treatment of agitation and aggression in Huntington's disease, J Neuropsychiatry Clin Neurosci, vol.25, pp.33-37, 2013. ,
Drug treatment in 117 cases of Huntington's disease with special reference to fluphenazine (Prolixin), Psychiatr Q, vol.41, pp.203-213, 1967. ,
Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease, Parkinsonism Relat Disord, vol.44, pp.95-100, 2017. ,
Rapid eye movement sleep disturbances in Huntington disease, Arch Neurol, vol.65, pp.482-490, 2008. ,
Efficiency of carbamazepine in the treatment of micturitional disturbances in Huntington disease, Neurology, vol.55, p.1934, 2000. ,
Access to special care dentistry, part 7. Special care dentistry services: seamless care for people in their middle years-part 1, Br Dent J, vol.205, pp.305-322, 2008. ,
Guideline for oral healthcare of adults with Huntington's disease, Neurodegener Dis Manag, vol.2, pp.55-65, 2012. ,
Providing dental care for patients with Huntington's disease. Dent Update, vol.35, pp.333-339, 2008. ,
Huntington's chorea: review and case report, Gen Dent, vol.33, pp.131-134, 1985. ,
Huntington's disease: review and anesthetic case management, Anesth Prog, vol.45, pp.150-153, 1998. ,
Early enteric neuron dysfunction in mouse and human Huntington disease, Parkinsonism Relat Disord, vol.34, pp.73-77, 2017. ,
Nutritional management of individuals with Huntington's disease: nutritional guidelines, Neurodegener Dis Manage, vol.2, pp.33-43, 2012. ,
Assessment of the nutrition status of patients with Huntington's disease, Nutrition, vol.20, pp.192-198, 2004. ,
Effect of donepezil on motor and cognitive function in Huntington disease, Neurology, vol.67, pp.1268-71, 2006. ,
Dysphagia in Huntington's disease, Arch Neurol, vol.42, pp.57-60, 1985. ,
Characteristics of individuals with Huntington disease in long-term care, Mov Disord, vol.11, pp.542-550, 1996. ,
Use of oral nutritional supplements in patients with Huntington's disease, Nutrition, vol.21, pp.889-94, 2005. ,
Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease, Eur J Endocrinol, vol.151, pp.451-456, 2004. ,
J14 mediterranean diet and nutritional composition of patients with Huntington's disease. Spanish multicenter study of the European group for Huntington's disease, J Neurol Neurosurg Psychiatry, pp.69-70, 2014. ,
The relationship between dietary intake, nutrition status and Huntington's disease severity (P1.050), Neurology, vol.4, pp.78-85, 2014. ,
Respiratory muscle training on pulmonary and swallowing function in patients with Huntington's disease: a pilot randomised controlled trial, Clin Rehabil, vol.29, pp.961-73, 2015. ,
Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease, Drug Des Devel Ther, vol.12, pp.313-322, 2018. ,
Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial, JAMA, vol.316, pp.40-50, 2016. ,
Physical activity self-management and coaching compared to social interaction in Huntington disease: results from the ENGAGE-HD randomized, controlled pilot feasibility trial, Phys Ther, vol.97, pp.625-664, 2017. ,
Exercise effects in Huntington disease, J Neurol, vol.264, pp.32-41, 2017. ,
Effects of endurance training on skeletal muscle mitochondrial function in Huntington disease patients, Orphanet J Rare Dis, vol.19, p.184, 2017. ,
Is there an association of physical activity with brain volume, behavior, and day-to-day functioning? A cross sectional design in prodromal and early huntington disease ,
, PLoS Curr, vol.8, 2016.
Members of the Physiotherapy Working Group of the European Huntington's Disease Network. A classification system to guide physical therapy management in huntington disease: a case series, J Neurol Phys Ther, vol.41, pp.156-63, 2017. ,
, Disease Network (EHDN) during the completion of the work, and received honoraria for the duties involved in this position. AR received reimbursements as Co-Chair and Chair of the EHDN. RR is the owner of the George-HuntingtonInstitut GmbH and the QuantisMedis GmbH, Conflict of Interest Statement: J-MB was chair of the European Huntington's